TriSalus Expands Veteran Access to Liver Cancer Treatment with Geo-Med
Deal News | Nov 11, 2024 | Tullis-Dickerson & Co Inc
TriSalus Life Sciences, an oncology company focused on enhancing cancer treatment through advanced delivery technologies and investigational immunotherapies, has announced a strategic partnership with Geo-Med, LLC to expand the availability of the TriNav Infusion System to U.S. Veterans Affairs medical centers nationwide. This collaboration aims to provide veterans with access to TriNav's proprietary Pressure-Enabled Drug Delivery (PEDD) system, which has shown significant potential in improving liver cancer treatment outcomes. The strategic alliance leverages Geo-Med's expertise in supplying medical products to VA and DOD facilities, ensuring that veterans receive state-of-the-art cancer care. With hepatocellular carcinoma occurring at much higher rates among U.S. veterans, this initiative is particularly timely. The PEDD method offers improved therapeutic delivery while minimizing adverse effects, and this partnership underscores TriSalus's commitment to enhancing patient outcomes, especially for veterans. TriSalus, backed by Private Equity firm Tullis-Dickerson & Co, also expects that its investigational drug nelitolimod, delivered via PEDD, will further improve immune responses in affected patients.
Sectors
- Healthcare & Biotechnology
- Government & Defence
Geography
- United States – The article focuses on expanding healthcare services to U.S. veterans through VA medical centers, highlighting the geographical impact.
Industry
- Healthcare & Biotechnology – The article discusses advancements in cancer treatment and biotechnology, particularly in the realm of oncology with TriSalus's innovative technologies.
- Government & Defence – The partnership involves expanding medical technology to U.S. VA and DOD facilities, highlighting the industry's focus on veteran healthcare services.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| TriSalus Life Sciences Inc. | Target Company | Company | An oncology-focused medical technology company dedicated to improving drug delivery and patient outcomes for liver and pancreatic tumors. |
| Geo-Med, LLC | Partner | Company | A certified Service-Disabled Veteran-Owned Small Business providing medical products to VA and DOD facilities. |
| Tullis-Dickerson & Co Inc. | PE Firm | Company | Private equity backer of TriSalus Life Sciences. |
| U.S. Department of Veterans Affairs | Healthcare provider | Government | A government agency providing essential health services to U.S. veterans. |
| Mike Locke | CEO of Geo-Med | Person | Chief Executive Officer of Geo-Med, instrumental in the partnership with TriSalus. |
| Mary Szela | CEO and President of TriSalus | Person | Leading strategist for TriSalus's initiatives to enhance cancer treatment for veterans. |